163 related articles for article (PubMed ID: 17461700)
21. Efficacy of Botulinum Toxin, Local Anesthetics, and Corticosteroids in Patients With Piriformis Syndrome: A Systematic Review and Meta-analysis.
Hilal FM; Bashawyah A; Allam AE; Lam KHS; El Oumri AA; Galluccio F; AlKharabsheh A; Kaye AD; Salti A; Varrassi G
Pain Physician; 2022 Aug; 25(5):325-337. PubMed ID: 35901473
[TBL] [Abstract][Full Text] [Related]
22. Botulinum toxin and intractable trigeminal neuralgia.
Türk U; Ilhan S; Alp R; Sur H
Clin Neuropharmacol; 2005; 28(4):161-2. PubMed ID: 16062093
[TBL] [Abstract][Full Text] [Related]
23. A double-blind, controlled, randomized trial to evaluate the efficacy of botulinum toxin for the treatment of lumbar myofascial pain in humans.
De Andrés J; Adsuara VM; Palmisani S; Villanueva V; López-Alarcón MD
Reg Anesth Pain Med; 2010; 35(3):255-60. PubMed ID: 20921836
[TBL] [Abstract][Full Text] [Related]
24. The effectiveness of clonidine-bupivacaine repeated nerve stimulator-guided injection in piriformis syndrome.
Naja Z; Al-Tannir M; El-Rajab M; Ziade F; Daher Y; Khatib H; Tayara K
Clin J Pain; 2009; 25(3):199-205. PubMed ID: 19333169
[TBL] [Abstract][Full Text] [Related]
25. Comparison of lidocaine injection, botulinum toxin injection, and dry needling to trigger points in myofascial pain syndrome.
Kamanli A; Kaya A; Ardicoglu O; Ozgocmen S; Zengin FO; Bayik Y
Rheumatol Int; 2005 Oct; 25(8):604-11. PubMed ID: 15372199
[TBL] [Abstract][Full Text] [Related]
26. Effect of electrical stimulation on botulinum toxin a therapy in patients with chronic myofascial pain syndrome: a 16-week randomized double-blinded study.
Seo HG; Bang MS; Chung SG; Jung SH; Lee SU
Arch Phys Med Rehabil; 2013 Mar; 94(3):412-8. PubMed ID: 23123438
[TBL] [Abstract][Full Text] [Related]
27. Treatment of shoulder pain in spastic hemiplegia by reducing spasticity of the subscapular muscle: a randomised, double blind, placebo controlled study of botulinum toxin A.
Yelnik AP; Colle FM; Bonan IV; Vicaut E
J Neurol Neurosurg Psychiatry; 2007 Aug; 78(8):845-8. PubMed ID: 17088333
[TBL] [Abstract][Full Text] [Related]
28. Botulinum toxin type A as a migraine preventive treatment. For the BOTOX Migraine Clinical Research Group.
Silberstein S; Mathew N; Saper J; Jenkins S
Headache; 2000 Jun; 40(6):445-50. PubMed ID: 10849039
[TBL] [Abstract][Full Text] [Related]
29. A pilot study comparing the efficacy of two formulations of botulinum toxin type A for muscular calves contouring.
Wanitphakdeedecha R; Ungaksornpairote C; Kaewkes A; Sathaworawong A; Vanadurongwan B; Lektrakul N
J Cosmet Dermatol; 2018 Dec; 17(6):984-990. PubMed ID: 30203534
[TBL] [Abstract][Full Text] [Related]
30. Comparison between botulinum toxin and corticosteroid injection in the treatment of acute and subacute tennis elbow: a prospective, randomized, double-blind, active drug-controlled pilot study.
Lin YC; Tu YK; Chen SS; Lin IL; Chen SC; Guo HR
Am J Phys Med Rehabil; 2010 Aug; 89(8):653-9. PubMed ID: 20134306
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of Intralesional Botulinum Toxin A for Treatment of Painful Cutaneous Leiomyomas: A Randomized Clinical Trial.
Naik HB; Steinberg SM; Middelton LA; Hewitt SM; Zuo RC; Linehan WM; Kong HH; Cowen EW
JAMA Dermatol; 2015 Oct; 151(10):1096-102. PubMed ID: 26244563
[TBL] [Abstract][Full Text] [Related]
32. Botulinum toxin type A as an effective prophylactic treatment in primary headache disorders.
Blumenfeld A
Headache; 2003 Sep; 43(8):853-60. PubMed ID: 12940806
[TBL] [Abstract][Full Text] [Related]
33. Computer-tomographic verification of ultrasound-guided piriformis muscle injection: a feasibility study.
Fabregat G; Roselló M; Asensio-Samper JM; Villaneuva-Pérez VL; Martínez-Sanjuan V; De Andrés J; Eichenberger U
Pain Physician; 2014; 17(6):507-13. PubMed ID: 25415775
[TBL] [Abstract][Full Text] [Related]
34. Abobotulinum toxin A and onabotulinum toxin A for masseteric hypertrophy: a split-face study in 25 Korean patients.
Lee SH; Wee SH; Kim HJ; Yeo UC; Lee NH; Lee SW; Cho SB
J Dermatolog Treat; 2013 Apr; 24(2):133-6. PubMed ID: 21888570
[TBL] [Abstract][Full Text] [Related]
35. Effects of lidocaine incorporation (without epinephrine) on pain and 2-week complications of botulinum toxin: a double-blind randomized placebo-controlled clinical trial.
Sarkarat F; Bagheri D; Kahali R; Fateh A; Rakhshan V
Sci Rep; 2023 May; 13(1):7812. PubMed ID: 37183235
[TBL] [Abstract][Full Text] [Related]
36. Botulinum toxin A for myofascial trigger point injection: a qualitative systematic review.
Ho KY; Tan KH
Eur J Pain; 2007 Jul; 11(5):519-27. PubMed ID: 17071119
[TBL] [Abstract][Full Text] [Related]
37. Adhesive taping vs. daily manual muscle stretching and splinting after botulinum toxin type A injection for wrist and fingers spastic overactivity in stroke patients: a randomized controlled trial.
Santamato A; Micello MF; Panza F; Fortunato F; Picelli A; Smania N; Logroscino G; Fiore P; Ranieri M
Clin Rehabil; 2015 Jan; 29(1):50-8. PubMed ID: 24917588
[TBL] [Abstract][Full Text] [Related]
38. Botulinum toxin injection into the forearm muscles for wrist and fingers spastic overactivity in adults with chronic stroke: a randomized controlled trial comparing three injection techniques.
Picelli A; Lobba D; Midiri A; Prandi P; Melotti C; Baldessarelli S; Smania N
Clin Rehabil; 2014 Mar; 28(3):232-42. PubMed ID: 23945164
[TBL] [Abstract][Full Text] [Related]
39. The value of local botulinum toxin A injection in the treatment of the pain of aphthous ulcer.
Yang TY; Jang TY
Eur Arch Otorhinolaryngol; 2009 Mar; 266(3):445-8. PubMed ID: 18584189
[TBL] [Abstract][Full Text] [Related]
40. A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome.
Wheeler AH; Goolkasian P; Gretz SS
Spine (Phila Pa 1976); 1998 Aug; 23(15):1662-6; discussion 1667. PubMed ID: 9704373
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
